Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Van der Geld, YM; Huitema, MG; Franssen, CFM; Van der Zee, R; Limburg, PC; Kallenberg, CGM
   In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)
   CLINICAL AND EXPERIMENTAL IMMUNOLOGY
   
   Y.M. Van der Geld et al., "In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)", CLIN EXP IM, 122(3), 2000, pp. 504-513
2. Foucher, P; Heeringa, P; Petersen, AH; Huitema, MG; Brouwer, E; Tervaert, JWC; Prop, J; Camus, P; Weening, FJ; Kallenberg, CGM
   Antimyeloperoxidase-associated lung disease - An experimental model
   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
   
   P. Foucher et al., "Antimyeloperoxidase-associated lung disease - An experimental model", AM J R CRIT, 160(3), 1999, pp. 987-994
3. Franssen, CFM; Huitema, MG; Kobold, ACM; Oost-Kort, WW; Limburg, PC; Tiebosch, A; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
   In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   C.F.M. Franssen et al., "In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis", J AM S NEPH, 10(7), 1999, pp. 1506-1515
4. HEERINGA P; VANGOOR H; MOSHAGE H; KLOK PA; HUITEMA MG; DEJAGER A; SCHEP AJ; KALLENBERG CGM
   EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE-MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS
   Kidney international
   
   P. Heeringa et al., "EXPRESSION OF INOS, ENOS, AND PEROXYNITRITE-MODIFIED PROTEINS IN EXPERIMENTAL ANTIMYELOPEROXIDASE ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS", Kidney international, 53(2), 1998, pp. 382-393
5. HARMSEN MC; HEERINGA P; VANDERGELD YM; HUITEMA MG; KLIMP A; TIRAN A; KALLENBERG CGM
   RECOMBINANT PROTEINASE-3 (WREGENERS ANTIGEN) EXPRESSED IN PICHIA-PASTORIS IS FUNCTIONALLY ACTIVE AND IS RECOGNIZED BY PATIENT SERA
   Clinical and experimental immunology
   
   M.C. Harmsen et al., "RECOMBINANT PROTEINASE-3 (WREGENERS ANTIGEN) EXPRESSED IN PICHIA-PASTORIS IS FUNCTIONALLY ACTIVE AND IS RECOGNIZED BY PATIENT SERA", Clinical and experimental immunology, 110(2), 1997, pp. 257-264
6. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
   SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT
   The American journal of pathology
   
   P. Heeringa et al., "SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT", The American journal of pathology, 151(1), 1997, pp. 131-140
7. HEERINGA P; KLOK PA; HUITEMA MG; VANDENBORN J; WEENING JJ; KALLENBERG CGM
   AUTOANTIBODIES TO MYELOPEROXIDASE AGGRAVATE MILD IMMUNE-MEDIATED GLOMERULAR INJURY IN THE RAT
   Journal of the American Society of Nephrology
   
   P. Heeringa et al., "AUTOANTIBODIES TO MYELOPEROXIDASE AGGRAVATE MILD IMMUNE-MEDIATED GLOMERULAR INJURY IN THE RAT", Journal of the American Society of Nephrology, 7(9), 1996, pp. 2279-2279
8. SPRONK PE; BOOTSMA H; HORST G; HUITEMA MG; LIMBURG PC; TERVAERT JWC; KALLENBERG CGM
   ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
   British journal of rheumatology
   
   P.E. Spronk et al., "ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS", British journal of rheumatology, 35(7), 1996, pp. 625-631
9. HEERINGA P; VANDENBORN J; BROUWER E; DOLMAN KM; KLOK PA; HUITEMA MG; LIMBURG PC; BAKKER MAH; BERDEN JHM; DAHA MR; KALLENBERG CGM
   ELASTASE, BUT NOT PROTEINASE-3 (PR3), INDUCES PROTEINURIA ASSOCIATED WITH LOSS OF GLOMERULAR-BASEMENT-MEMBRANE HEPARAN-SULFATE AFTER IN-VIVO RENAL PERFUSION IN RATS
   Clinical and experimental immunology
   
   P. Heeringa et al., "ELASTASE, BUT NOT PROTEINASE-3 (PR3), INDUCES PROTEINURIA ASSOCIATED WITH LOSS OF GLOMERULAR-BASEMENT-MEMBRANE HEPARAN-SULFATE AFTER IN-VIVO RENAL PERFUSION IN RATS", Clinical and experimental immunology, 105(2), 1996, pp. 321-329
10. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; KALLENBERG CGM
    SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS
    Arthritis and rheumatism
    
    P. Heeringa et al., "SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS", Arthritis and rheumatism, 39(9), 1996, pp. 85-85
11. HEERINGA P; KLOK PA; HUITEMA MG; BROUWER E; KALLENBERG CGM
    EXPERIMENTAL ANTI-MPO ASSOCIATED PROLIFERATIVE GLOMERULONEPHRITIS - THE ROLE OF ANTIBODIES AND COMPLEMENT
    Journal of the American Society of Nephrology
    
    P. Heeringa et al., "EXPERIMENTAL ANTI-MPO ASSOCIATED PROLIFERATIVE GLOMERULONEPHRITIS - THE ROLE OF ANTIBODIES AND COMPLEMENT", Journal of the American Society of Nephrology, 6(3), 1995, pp. 867-867
12. HEERINGA P; FOUCHER P; KLOK RA; HUITEMA MG; TERVAERT JWC; KALLENBERG CGM
    SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASEIMMUNIZED BROWN-NORWAY RATS
    Journal of the American Society of Nephrology
    
    P. Heeringa et al., "SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASEIMMUNIZED BROWN-NORWAY RATS", Journal of the American Society of Nephrology, 6(3), 1995, pp. 868-868
13. HEERINGA P; KLOK PA; HUITEMA MG; FOUCHER P; KALLENBERG CGM
    INTRARENAL INJECTION OF LIPOPOLYSACCHARIDE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS
    Kidney international
    
    P. Heeringa et al., "INTRARENAL INJECTION OF LIPOPOLYSACCHARIDE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS", Kidney international, 48(4), 1995, pp. 1365-1365
14. BROUWER E; KLOK PA; HUITEMA MG; WEENING JJ; KALLENBERG CGM
    RENAL ISCHEMIA-REPERFUSION INJURY CONTRIBUTES TO RENAL DAMAGE IN EXPERIMENTAL ANTI-MYELOPEROXIDASE-ASSOCIATED PROLIFERATIVE GLOMERULONEPHRITIS
    Kidney international
    
    E. Brouwer et al., "RENAL ISCHEMIA-REPERFUSION INJURY CONTRIBUTES TO RENAL DAMAGE IN EXPERIMENTAL ANTI-MYELOPEROXIDASE-ASSOCIATED PROLIFERATIVE GLOMERULONEPHRITIS", Kidney international, 47(4), 1995, pp. 1121-1129
15. SPRONK PE; BOOTSMA H; HUITEMA MG; LIMBURG PC; KALLENBERG CG
    LEVELS OF SOLUBLE ADHESION MOLECULES DURING DISEASE RELAPSES OF SYSTEMIC LUPUS-ERYTHEMATOSUS - A LONG-TERM PROSPECTIVE-STUDY
    Journal of the American Society of Nephrology
    
    P.E. Spronk et al., "LEVELS OF SOLUBLE ADHESION MOLECULES DURING DISEASE RELAPSES OF SYSTEMIC LUPUS-ERYTHEMATOSUS - A LONG-TERM PROSPECTIVE-STUDY", Journal of the American Society of Nephrology, 5(3), 1994, pp. 652-652
16. HEERINGA P; BROUWER E; KLOK PA; HUITEMA MG; BAKKER M; VANDENBORN J; BERDEN J; DAHA MR; KALLENBERG CGM
    ELASTASE BUT NOT PROTEINASE-3 INDUCES PROTEINURIA AFTER IN-VIVO RENALPERFUSION
    Journal of the American Society of Nephrology
    
    P. Heeringa et al., "ELASTASE BUT NOT PROTEINASE-3 INDUCES PROTEINURIA AFTER IN-VIVO RENALPERFUSION", Journal of the American Society of Nephrology, 5(3), 1994, pp. 781-781
17. BROUWER E; KLOK PA; HUITEMA MG; WEENING JJ; KALLENBERG CGM
    RENAL ISCHEMIA CONTRIBUTES TO RENAL DAMAGE IN RAT MODEL OF ANTIMYELOPEROXIDASE ASSOCIATED NECROTIZING CRESCENTIC GLOMERULONEPHRITIS (NCGN)
    Kidney international
    
    E. Brouwer et al., "RENAL ISCHEMIA CONTRIBUTES TO RENAL DAMAGE IN RAT MODEL OF ANTIMYELOPEROXIDASE ASSOCIATED NECROTIZING CRESCENTIC GLOMERULONEPHRITIS (NCGN)", Kidney international, 46(5), 1994, pp. 1459-1459
18. BROUWER E; HUITEMA MG; MULDER AHL; HEERINGA P; VANGOOR H; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
    NEUTROPHIL ACTIVATION IN-VITRO AND IN-VIVO IN WEGENERS GRANULOMATOSIS
    Kidney international
    
    E. Brouwer et al., "NEUTROPHIL ACTIVATION IN-VITRO AND IN-VIVO IN WEGENERS GRANULOMATOSIS", Kidney international, 45(4), 1994, pp. 1120-1131
19. BROUWER E; STEGEMAN CA; HUITEMA MG; LIMBURG PC; KALLENBERG CGM
    T-CELL REACTIVITY TO PROTEINASE-3 AND MYELOPEROXIDASE IN PATIENTS WITH WEGENERS GRANULOMATOSIS (WG)
    Clinical and experimental immunology
    
    E. Brouwer et al., "T-CELL REACTIVITY TO PROTEINASE-3 AND MYELOPEROXIDASE IN PATIENTS WITH WEGENERS GRANULOMATOSIS (WG)", Clinical and experimental immunology, 98(3), 1994, pp. 448-453
20. SPRONK PE; BOOTSMA H; HUITEMA MG; LIMBURG PC; KALLENBERG CGM
    LEVELS OF SOLUBLE VCAM-1, SOLUBLE ICAM-1, AND SOLUBLE E-SELECTIN DURING DISEASE EXACERBATIONS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS(SLE) - A LONG-TERM PROSPECTIVE-STUDY
    Clinical and experimental immunology
    
    P.E. Spronk et al., "LEVELS OF SOLUBLE VCAM-1, SOLUBLE ICAM-1, AND SOLUBLE E-SELECTIN DURING DISEASE EXACERBATIONS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS(SLE) - A LONG-TERM PROSPECTIVE-STUDY", Clinical and experimental immunology, 97(3), 1994, pp. 439-444
21. STEGEMAN CA; TERVAERT JWC; HUITEMA MG; DEJONG PE; KALLENBERG CGM
    SERUM LEVELS OF SOLUBLE ADHESION MOLECULES INTERCELLULAR-ADHESION MOLECULE-1, VASCULAR CELL-ADHESION MOLECULE-1, AND E-SELECTIN IN PATIENTSWITH WEGENERS GRANULOMATOSIS - RELATIONSHIP TO DISEASE-ACTIVITY AND RELEVANCE DURING FOLLOW-UP
    Arthritis and rheumatism
    
    C.A. Stegeman et al., "SERUM LEVELS OF SOLUBLE ADHESION MOLECULES INTERCELLULAR-ADHESION MOLECULE-1, VASCULAR CELL-ADHESION MOLECULE-1, AND E-SELECTIN IN PATIENTSWITH WEGENERS GRANULOMATOSIS - RELATIONSHIP TO DISEASE-ACTIVITY AND RELEVANCE DURING FOLLOW-UP", Arthritis and rheumatism, 37(8), 1994, pp. 1228-1235
22. TERVAERT JWC; STEGEMAN CA; HUITEMA MG; KALLENBERG CGM
    RELATIONSHIP BETWEEN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-LEVELS AND DISEASE-ACTIVITY IN WEGENERS GRANULOMATOSIS - COMMENT
    Arthritis and rheumatism
    
    J.W.C. Tervaert et al., "RELATIONSHIP BETWEEN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-LEVELS AND DISEASE-ACTIVITY IN WEGENERS GRANULOMATOSIS - COMMENT", Arthritis and rheumatism, 37(4), 1994, pp. 596-596
23. SPRONK PE; TERBORG EJ; HUITEMA MG; LIMBURG PC; KALLENBERG CGM
    CHANGES IN LEVELS OF SOLUBLE T-CELL ACTIVATION MARKERS, SIL-2R, SCD4 AND SCD8, IN RELATION TO DISEASE EXACERBATIONS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY
    Annals of the Rheumatic Diseases
    
    P.E. Spronk et al., "CHANGES IN LEVELS OF SOLUBLE T-CELL ACTIVATION MARKERS, SIL-2R, SCD4 AND SCD8, IN RELATION TO DISEASE EXACERBATIONS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY", Annals of the Rheumatic Diseases, 53(4), 1994, pp. 235-239
24. BROUWER E; DOLMAN KM; HUITEMA MG; KLOK PA; GOLDSCHMEDING R; WEENING JJ; KALLENBERG CGM
    RENAL PERFUSION OF PROTEINASE-3 - A NOVEL ELASTINOLYTIC ENZYME AND TARGET ANTIGEN OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES
    Kidney international
    
    E. Brouwer et al., "RENAL PERFUSION OF PROTEINASE-3 - A NOVEL ELASTINOLYTIC ENZYME AND TARGET ANTIGEN OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES", Kidney international, 44(5), 1993, pp. 1194-1194